Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study.

Massicotte, Marie-Hélène

Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study. [electronic resource] - The Journal of clinical endocrinology and metabolism Jun 2013 - 2401-8 p. digital

Publication Type: Controlled Clinical Trial; Journal Article

1945-7197

10.1210/jc.2013-1115 doi


Adult
Aged
Body Composition
Carcinoma, Neuroendocrine
Cross-Over Studies
Female
Humans
Male
Middle Aged
Muscle, Skeletal--metabolism
Piperidines--adverse effects
Protein Kinase Inhibitors--therapeutic use
Quinazolines--adverse effects
Thyroid Neoplasms--drug therapy